NCT06831344 - A Study to Evaluate Two Vonoprazan Orally Disintegrating Tablet Formulations Administered Without Water or Mixed With Water and Administered Via a Syringe Relative to the Vonoprazan Tablet in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

April 5, 2025

Study Completion Date

April 10, 2025

Conditions

Healthy Volunteers

Interventions

DRUG

Vonoprazan ODT-1 or ODT-2 without Water

Vonoprazan will be administered orally as an ODT-1 or ODT-2 without water

DRUG

Vonoprazan ODT-1 or ODT-2 with Water

Vonoprazan will be administered orally as an ODT-1 or ODT-2 with water via a syringe

DRUG

Vonoprazan (Reference)

Vonoprazan will be administered orally as a tablet

Trial Locations (1)

7551 Metro Center Dr Ste 200, Austin